Modelling acute renal failure using blood and breath biomarkers in rats by Moorhead, K.T. et al.
 1 
Modelling Acute Renal Failure using Blood and Breath 
Biomarkers in Rats 
Katherine T. Moorhead1, Jonathan V. Hill2, J. Geoffrey Chase3, Christopher E. 
Hann3, Jennifer M. Scotter4, Malina K. Storer4, Zoltan H. Endre2  
 
1Corresponding Author: Department of Mechanical Engineering, University of 
Canterbury, Private Bag 4800, Christchurch 8140, New Zealand  
(Tel: 0064-3-364-2987; e-mail: ktm19@student.canterbury.ac.nz) 
 
2Department of Medicine, University of Otago Christchurch School of Medicine,  
P.O. Box 4345, Christchurch 8140, New Zealand 
 
3Department of Mechanical Engineering, University of Canterbury, Private Bag 4800, 
Christchurch 8140, New Zealand 
 
4Syft Technologies Ltd., P.O. Box 28149, Christchurch 8242, New Zealand 
 
Keywords: Renal Function, Breath Biomarkers, Integral Fitting Method, Model-based 
Approximation, Tracer Kinetics, Differential Equations 
 
This research was conducted on a commercially available SIFT-MS instrument 
provided by Syft Technologies Ltd., and was supported by a New Zealand Tertiary 
Education Commission Top Achiever Doctoral Scholarship (UOCX5011). 
This study was approved was by the New Zealand Animal Ethics Committee 
(C09/07601). 
 2 
Abstract  
This paper compares three methods for estimating renal function, as tested in rats. 
Acute Renal Failure (ARF) was induced via a 60-minute bilateral renal artery clamp 
in 8 Sprague-Dawley rats and renal function was monitored for 1 week post-surgery. 
A two-compartment model was developed for estimating glomerular filtration via a 
bolus injection of a radio-labelled inulin tracer, and was compared with an estimated 
creatinine clearance method, modified using the Cockcroft-Gault equation for rats. 
These two methods were compared with Selected Ion Flow Tube-Mass Spectrometry 
(SIFT-MS) monitoring of breath analytes. Determination of renal function via SIFT-
MS is desirable since results are available non-invasively and in real time. Relative 
decreases in renal function show very good correlation between all 3 methods 
(R2=0.84, 0.91 and 0.72 for breath-inulin, inulin-creatinine, and breath-creatinine 
correlations, respectively), and indicate good promise for fast, non-invasive 
determination of renal function via breath testing. 
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1 Introduction 
Current clinical measurements of renal function rely on at least daily measurements 
of plasma creatinine. However, in Acute Renal Failure (ARF), plasma creatinine 
levels can be very slow to react to changes in GFR,  which can result in delays of 1-3 
days in the diagnosis of renal failure in clinical situations [1, 2], and thus lead to 
unacceptable delays in instituting treatment. It is these delays which have lead to the 
American Association of Nephrologists to call for a concerted effort at discovery of 
new and earlier biomarkers of ARF. Consequently, there have been no improvements in 
mortality in the management of ARF for over 50 years, despite the availability of many 
useful experimentally effective treatments [3]. 
 
Selected Ion Flow Tube-Mass Spectrometry (SIFT-MS) is an analytical technique for 
the real-time quantification of Volatile Organic Compounds (VOCs) in air or breath 
samples. By analyzing changes in VOC concentrations in breath over time, SIFT-MS 
can offer fast diagnosis of various conditions and diseases non-invasively and in real-
time.  Hence, if renal failure could be assessed at its onset via breath biomarkers, this 
technology would enable regular, easy assessment and monitoring. 
 
In this study, ARF was induced in 8 Sprague-Dawley rats. Renal function was 
monitored for 1 week following induction of ARF via plasma creatinine 
measurements, SIFT-MS breath sampling, and radio-labelled inulin clearance tests. 
The goal was to correlate changes in breath biomarkers with the current clinical and 
model-based gold standards. From these results, the potential for SIFT-MS 
technology was assessed. 
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1.1 Glomerular Filtration Rate (GFR) 
Glomerular Filtration Rate refers to the volume of plasma cleared by filtration 
through the glomerular capillaries into Bowman’s space of the kidney per unit time 
(Fig. 1), and is generally accepted as the best overall estimation of kidney function.  
Any substance that is freely filtered by the glomerulus and is not secreted or 
reabsorbed by the kidneys can be used to measure GFR. 
 
Fig. 1. Kidney Anatomy [4] 
 
1.2 Exogenous Markers for measuring GFR 
If an exogenous filtration marker, such as inulin, is used to measure GFR, it is 
injected into the plasma, and its clearance through the kidney can be measured using 
either constant infusion or bolus techniques [5-8]. Using the constant infusion 
technique, the exogenous marker is injected into the plasma at a constant rate until a 
steady state is achieved. At this point, Equation (1) is applied, where plasma and 
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timed urine samples are collected to determine the marker concentration (Urine Conc 
and Plasma Conc, µmol/L), and the rate of urine flow (Urine Flow, mL/min). 
 
ConcPlasma
FlowUrineConcUrineGFR ×=  (1) 
 
In practice, this technique has limitations, as it is difficult and slow to achieve a 
steady state. In contrast, bolus methods can be quickly carried out, and require only a 
single injection of the exogenous marker into the plasma, and serial blood sampling at 
defined intervals. Urine collection is not required. However, data analysis requires the 
application of a well defined mathematical model.  These exogenous marker studies 
are used primarily in research, and are the research gold-standard assessment. 
 
1.3 Endogenous Markers for measuring GFR 
Measuring GFR via the clearance of an exogenous marker (e.g. inulin) is time 
consuming, expensive, and not appropriate in most clinical settings. Hence, GFR is 
usually estimated using an endogenous marker, such as creatinine.  
 
A previously used standard method of measuring GFR, is the creatinine clearance 
utilizing a 24 hour urine collection method. Using urinary and plasma creatinine, 
Equation (1) allows calculation of the creatinine clearance. While this overestimates 
GFR by 10% or more because of tubular secretion of creatinine [9], it nevertheless 
allows an approximation of GFR. Short collection periods can be useful [10, 11], but 
their use remains controversial. 24 hour collections are also often flawed because of 
collection problems [6]. 
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Steady state serum creatinine is approximately inversely proportional to GFR, and 
hence GFR can be estimated without the requirement for a 24 hour urine collection. 
However, creatinine is not an ideal filtration marker because, in addition to being 
filtered by the glomerulus, it is also secreted by the proximal tubules, resulting in a 
clearance that exceeds GFR, particularly in ARF.  
 
Since creatinine generation is determined mainly via muscle mass and dietary intake, 
tubular secretion of creatinine depends on factors such as age, sex, race, body size 
and muscle mass, and can vary substantially between individuals and over time [7]. 
Equations such as the Cockcroft-Gault and the MDRD equations have been 
developed to try to correct for these limitations [12]. Additionally, extra-renal 
elimination of creatinine via intestinal bacteria can increase at low GFR, thus making 
the method misleading for those individuals outside the normal range of kidney 
function. Finally, in ARF plasma creatinine levels are very slow to react to changes in 
GFR, because of the associated increase in creatinine half-life. With a 5 fold 
reduction in GFR, the creatinine half-life would increase from a normal value of 4 
hours in man, to 20 hours. With 3-5 half lives required to reach a steady state, such a 
reduction in GFR would take approximately 80 hours to reach a new steady state. 
Until a new steady state is reached, the severity of the decrease in GFR cannot be 
ascertained by a serum creatinine measurement.  The greater the reduction in GFR, 
the longer this assessment will take. Hence, these methods are a useful clinical tool 
due to their ease, but may have significant error. 
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1.4 SIFT-MS Breath Sampling 
SIFT-MS is a quantitative mass spectrometric method that utilizes the chemical 
ionization of positively charged precursor ions that react with the VOCs in an air or 
breath sample introduced into a flow tube. Comparing the mass of the product ions in 
a database, the identity of the sample VOCs can be established [13]. Changes in VOC 
concentration over time can provide an indication of disease progress. In this study, 
ammonia is the VOC of interest, since blood and breath ammonia increase in 
impaired renal function. 
 
1.5 Summary 
Overall, this paper compares 3 methods of renal function assessment. SIFT-MS is the 
new potential and non-invasive method. In contrast, creatinine clearance and 
exogenous inulin bolus are existing clinical and research standards. The outcome of 
this comparison will thus indicate both the differences in test accuracy or resolution, 
and the clinical applicability or context. 
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2 Methodology 
2.1 Experimental Method 
Female Sprague-Dawley rats (280-320g, n=8) were housed at 21oC in a 12 hour 
light/dark cycle, and allowed free access to food and water.  Under ketamine/domitor 
anaesthesia, an in-dwelling cannula was inserted into the jugular vein for the purposes 
of fast serial blood sampling.  GFR was monitored via plasma creatinine, SIFT-MS 
breath sampling, and bolus inulin clearance for 5 days while the animal recovered 
from surgery.  In a subsequent surgery, the renal arteries were exposed via a single 
mid-ventral incision, and clamped for 60 minutes, creating ARF via an ischemic 
event.  GFR was monitored for 7 days using the same 3 techniques, as the animal 
recovered and renal function returned to normal levels. The GFR monitoring schedule 
is shown in Table 1. 
Table 1.  GFR Monitoring Schedule 
Method 
Monitoring Time Points 
Post-Cannulation Post-ARF 
Plasma 
Creatinine 
6hr, 2day 
1hr, 6hr, 20hr, 30hr, 2day, 
4day, 7day 
Inulin 
Clearance 
6hr, 2day 6hr, 30hr, 2day, 4day, 7day 
SIFT-MS 
Breath 
-4hr, 1hr, 6hr, 20hr, 
30hr, 2 day, 5 day 
-4hr,1hr, 6hr, 20hr, 30hr, 
2day, 3day, 4day,5day, 7day 
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2.1 Radio-labelled Inulin Clearance 
14C labelled inulin (1 µCi of 1.12 µCi/mg dissolved in 0.1mL ionised water, diluted 
1:4 with saline) was injected into the jugular vein cannula of a conscious animal over 
2 seconds, and flushed with heparinised saline. A 150µL blood sample was collected 
via the jugular vein cannula at -1, 1.5, 3, 6, 12, 20, 40, 70 minutes post-bolus, and 
sent for scintillation analysis. At 1 minute prior to injecting the bolus, an additional 
150µL blood was collected for creatinine analysis. Red cells and remaining blood 
plasma were returned to the animal via the jugular vein after each experiment. 
 
2.2 Breath Sampling via SIFT-MS 
Direct breath was collected from conscious rats by wrapping the rat in a towel and 
placing it into a 300mL bottle (Fig. 2).   
 
Fig. 2. Breath Collection Apparatus 
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SIFT-MS Flow 
Tube 
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A background air sample was also obtained at each rat breath sample time-point. The 
tightness of the fit in the bottle combined with wrapping the rat in a towel minimized 
contamination from the fur and waste products.  Breathing holes were located 
posterior to the position of the rats’ nose.  Breath was drawn directly from the bottle 
through the SIFT-MS machine at 2mL/sec via a small straw attached to the end of the 
bottle. Because rats of this size have a breath flow rate of 2-3mL/sec, background air 
plays a significant role.   
 
Excretion and uptake of VOCs in the breath depends on the ventilation/perfusion ratio 
in the lung, and the concentration gradients of the substances across the respiratory 
surface and between the alveolar and environmental gas. Therefore, a subject 
breathing in an environment with a low VOC concentration will measure different 
alveolar VOC concentrations to the same subject breathing in a high VOC 
environment because of the different concentration gradient for diffusion. Similarly, 
when the external VOC concentration becomes higher than the endogenous 
concentration, the VOC will diffuse into blood instead of appearing in the exhaled 
breath.  
 
The low breath flow rate of rats, combined with the relatively high sampling rate of 
the Voice100 SIFT-MS machine, means that a highly mixed sample made up of the 
background air as well as the (background-air-dependent) alveolar breath, was tested. 
Most studies use mixed expiratory sampling, which includes deadspace air and hence 
artificially dilutes (for endogenous substances), or concentrates (for external 
contaminants) the measured analyte. However, if background air is also sampled, and 
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the deadspace volume can be accounted for, the alveolar fraction of the breath can be 
extracted [14-17]. 
 
The most common method for breath testing in large animals is via a face-mask with 
a non-rebreathing valve, and collecting the breath exhalate into a bag. In small 
animals, the animal is usually placed in a sealed chamber until desired analytes reach 
detectable levels. In anaesthetised animals, breath is usually collected directly using 
endotracheal intubation [18]. In this study, direct breath was deemed preferable to 
breath collection in tedlar bags due to the difficulty in remote collection of ammonia 
[19]. Endotracheal intubation was not considered for the primary breath sampling 
method in the main trial because it requires the animal to be anaesthetised. Due to the 
number of breath samples required, this method was deemed impractical, considering 
the risks of repeated anaesthesia, and animal ethics.  
 
The option to place the animal in a sealed chamber, and wait for analyte 
concentrations to build up was discarded for two main reasons. Firstly, to simply wait 
for detectable analyte levels to be obtained is inefficient, since the analyte will 
continue to build up after alveolar gas concentrations are reached. To wait for this 
pseudo-equilibrium would be dangerous for the rat, since it involves re-breathing and 
thus concentrating CO2 in the blood and risking hypercapnia. Secondly, the sample 
collected would be contaminated by fur and waste products, for example if the animal 
urinated whilst in the chamber.  
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The face-mask option with re-breathing valve commonly used for breath sampling in 
large animals was attempted for the rat. A latex mask was attached to straw with a 
simple reed valve, allowing the rat to breath from the room air, and forcing breath 
unidirectionally down the straw to the mass spectrometer. Due to the low pressures 
involved because of the small size of the animal, combined with the difficulty in 
forming a seal around the mask, activating the valves was very difficult. In addition, 
because of the small tidal volume, deadspace was a significant problem. Lastly, it was 
very stressful for the rat to be forced into the mask, likely elevating stress markers, 
such as pentane in the breath. Valved methods such as utilised in humans for 
discarding the dead-space portion of the breath and maintaining the alveolar breath 
for sampling were also discarded as impractical in the rat. 
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3 Mathematical Models 
3.1 Inulin Clearance 
Injection of an inulin bolus into the blood is described by the 2-compartment model in 
Fig. 3, where the bolus is injected into the plasma compartment, P, (with distribution 
volume VP), and moves bi-directionally between the interstitial compartment, Q, 
(distribution volume VQ), as described by n2 and n3 before being eliminated from the 
plasma via the kidneys, as described by n1. 
 
Fig. 3. Two-Compartment Model of Kidney Function 
 
The differential equations describing the amount of inulin in the 2 compartments are 
dependent on the three rate constants n1 - n3, and the inulin mass in both 
compartments, p(t) and q(t), as described in Equations (2) and (3). 
 
 )()()()()( 231 tutqntpnntpdt
d
+++−=  (2) 
 
 )()()( 32 tpntqntqdt
d
+−=  (3) 
 
 
In terms of concentrations, where P(t) = p(t)/VP and Q(t) = q(t)/VQ, and defining  α= 
VQ/VP, Equations (2) and (3) become: 
P Q 
n1 
n3 
n2 
u(t) 
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Since transport is assumed to be passive between plasma and interstitial 
compartments, the volume flowrate between compartments must be equal, indicating 
a diffusion-based transport, as defined in Equation (6). 
 
 QP VnVn 23 =  (6) 
 
It is assumed that the bolus is given so quickly that the concentration in the interstitial 
compartment, Q(t), is initially zero (as verified by the -1 minute blood sample). The 
bolus is therefore modelled as a unit impulse function at time zero, as described in 
Equation (7), where P(0) is the inulin concentration in the plasma compartment at 
time zero, and δ(t) is the Dirac delta function. 
 
 )()0()( tVPtu Pδ=  (7) 
 
Equation (7) is a reasonable simplification given there is no extra information to be 
obtained by modelling the initial rise in plasma inulin concentration, giving the 
physical limitations of gaining a sufficient number of accurate sample datapoints 
within the first minute after injection of the bolus. This assumption also indicates that 
the initial concentration in the plasma compartment is determined from the size of the 
injected bolus and the plasma volume. Combining Equations (4), (5), (6) and (7) 
yields: 
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 )()0())()(()()( 21 tPtQtPntPntP δα +−−−=  (8) 
 ))()(()( 2 tQtPntQ −=  (9) 
 
Equations (8) and (9) can be solved by standard non-linear regression [20]. However, 
as with any non-linear regression there can be problems with the existence of local 
minima. In addition, it can be computationally expensive due to the requirement for 
extensive forward simulations of the model. A detailed analysis of this phenomenon 
in a similar model is given in [21]. The method proposed is an extension of the 
integral method in [21] and is similar to the approach in [22]. It is very fast 
computationally.  
 
The method starts by integrating Equation (8) to obtain an approximation to P(t) in 
terms of the unknowns n1 and n2. A system of equations is then set up as defined in 
Equation (10), and solved for n1 and n2 using linear least squares. 
 
 [ ])()0())()(()(
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00
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n
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−=








 −∫∫ α  (10) 
 
Note that Equation (10) will have to be integrated over several different time intervals 
in the test to yield a solvable system of equations. The initial approximation of P(t) is 
a linear piecewise approximation obtained from the measured time and concentration 
data, and P(0) is the estimated average inulin concentration in the plasma 
immediately after injection of the bolus, defined as the product of the bolus volume 
and concentration, divided by the estimated plasma volume of the animal based on its 
weight. Using the obtained solution for n1 and n2, a new approximation for P(t) is 
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generated. Constraints are added to the least squares solution to keep the 
approximation within known physiological ranges. However, there are no 
measurements for Q(t), hence a different approach is required to analyse the 
interstitial compartment. 
 
Given the approximation for P(t), Q(t) can be found analytically using the 
convolution integral solution to Equation (9), given in (11). 
 
 ∫ −−=
t tn dePntQ
0
)(
2
2)()( ττ τ  (11) 
 
Iterations between P(t) and new estimates of Q(t) to update P(t) in Equation (10) 
continue until convergence is achieved in the parameter values. The method is 
repeated for α values within the physiologically reported range of 2.2 - 4.5 [23, 24], 
until a least squares solution is found for α. 
 
3.2 Plasma Creatinine 
The Cockcroft-Gault equation for GFR in humans is: 
 
 
Cr
femaleifwtage
ClearanceCreatinine
72
)85.0)()(140( −
=  (12) 
 
where age is patients age (years), wt is their mass (kg), and Cr is the plasma 
creatinine concentration (mg/dL).  All animals in the present study were female and 
approximately the same age. Therefore, by plotting GFR (mL/min) values generated 
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using the inulin clearance method against 
Cr
mass for all rats at all time points, Fig. 4 
and Equation (13) were obtained, with a Pearson product-moment correlation 
coefficient (R-value) of R = 0.94.  
 
Cr
masskgmolGFR   min//10220 3 ××= − µ  (13) 
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Fig. 4. Relationship between Creatinine, Mass and GFR 
 
3.3 SIFT-MS Breath Sampling 
A pilot study was conducted to determine the relationship between rat breath and 
background air in the experimental set-up described in Section 2.2. Healthy, 
conscious rats were allowed to equilibrate in a room containing a controlled 
concentration of ammonia. By increasing the concentration of the background 
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ammonia, CB, and measuring the sample collected in the bottle, CTot, Fig. 5 was 
obtained. 
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Fig. 5. Relationship between Background and Breath in healthy rats 
 
Linear regression yields Equation (14), with an R-value of 0.99, where the x-intercept 
represents the concentration of the analyte in breath given a zero concentration in 
background air. The slope of CTot greater than 1 indicates that ammonia was 
concentrated in the breath against its concentration gradient from the blood, an 
interesting, unique finding that has not been previously described. 
 
 ppbCC BTot 5946.1 +×=  (14) 
 
For simple diffusion down a concentration gradient, as usually reported for transport 
across lung epithelial cells, it was expected that when plotted against CB, the lines 
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CTot and CB should intersect at a point where the concentrations are equal. At 
background air concentrations below the point of intersection, the analyte diffuses out 
of the blood, and at background air concentrations greater than the point of 
intersection, the analyte diffuses into the blood. Hence, this finding in Fig. 5 and 
Equation (14) suggests the presence of actively energised ammonia transporters in the 
lung capillaries or epithelia, which are capable of transporting ammonia against a 
concentration gradient such that ammonia appears to be exhaled at concentration 
greater than that of the background air or the blood. Another possible explanation is 
that ammonia and its metabolites are removed from the blood and concentrated in the 
lung tissue, thus providing a sink for diffusion into the alveolar air. Cooper and Freed 
[25] injected a [13N] ammonia bolus into the femoral vein of anaesthetised rats and 
measured its clearance from the blood. Results showed that nearly 30% of the label 
was removed by the lungs in the first pass, supporting the theory for an ammonia 
sink. However, they did not measure large quantities of ammonia in the expired air. A 
third possible explanation is an increase in the action of the enzyme urease in the oral 
cavity, which converts urea to ammonia. However, this effect is expected to be less 
pronounced in rats since they are obligate nose breathers. 
 
A lumped parameter model for the breath circuit is shown in Fig. 6, where the 
air/breath moving into and out of the bottle is considered. In this model, the rat is 
breathing at a volume flow rate of VR ml/sec, and breathes in and out concentrations 
of CTot and CR, respectively. In Fig. 6, this corresponds to air leaving the bottle at a 
volume flow rate of VR ml/sec and concentration of CTot as the rat breathes in, and 
breath entering the bottle at a volume flow rate of VR ml/sec and concentration of CR 
as the rat breathes out. SIFT-MS draws the sample at 2mL/sec, and thus background 
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air must be drawn into the bottle at 2mL/sec to maintain equilibrium. The volume 
flow rate of rat breath is calculated from tidal volume and respiratory rate, which for a 
250-300g rat, is approximately 2.7mL/sec [26].   
 
Fig. 6. Rat Breathing Circuit 
 
Using conservation of mass, CR can be calculated: 
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Plotting CR against CB and fitting a linear regression, as in Fig. 5 and Equation (14), 
yields: 
 
 ppbCC BR 10279.1 +×=  (16) 
 
Bottle CTot @ VB=2mL/sec 
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Rat breathing out 
CTot @ VR mL/sec 
Rat breathing in 
 21 
Note that the CR obtained from Equation (16) is specific for a healthy rat. Hence, 
Equations (15) and (16) are combined to normalise a given rat concentration, CR, to a 
healthy rat concentration at that background air concentration, as seen in Equation 
(17). 
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=  (17) 
 
CR* was plotted against time, following the course of each surgical intervention.  
Hence, each rat provided their own control from the first surgery to ensure that it was 
the ARF and not surgery alone causing the rise in breath ammonia. Using this 
method, a percentage increase in breath ammonia can be reported for each rat.  
 
Alternatively, breath ammonia can be converted to GFR by plotting GFR obtained via 
inulin clearance against CR* for all rats at all time-points (Fig. 7). Hence, GFR can be 
estimated from breath ammonia using the linear regression of Equation (18), which 
results in a R-value of 0.89.  Note that domitor, used in the anesthetic cocktail, causes 
a 70% depression in respiration. Therefore, the ratio VB/VR increases during surgery 
and recovery from anesthesia. 
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Fig. 7. Relationship between Breath Ammonia and GFR 
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4 Results and Discussion 
4.1 Bolus Radio-labelled Inulin Clearance Test 
Using the iterative integral fitting method, clearance curves were obtained for each rat 
at each time-point. Due to the difficulty in keeping the jugular vein cannula patent for 
12 days, some animals did not undergo the full contingent of 7 inulin clearance tests. 
Fig. 8 shows a typical inulin clearance curve obtained for a rat in the normal and ARF 
states. The average curve fitting error was less than 10%. 
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Fig. 8. Inulin Clearance Curve 
 
Table 2 summarizes the inulin clearance test results. The maximum decrease in GFR 
was observed in the first clearance test post-ARF, at the 6 hour time-point. 
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Table 2.  Inulin GFR Estimation 
Rat Weight (g) 
GFR (mL/min)* 
% decrease 
Model % 
error Normal ARF 
1 299 2.60 0.95 63 8.2 
2 300 2.50 0.40 84 7.3 
3 300 2.67 0.81 70 9.1 
4 302 2.39 1.1 54 9.1 
5 291 2.74 0.91 67 8.9 
6 280 2.35 1.05 55 10.9 
7 306 3.17 1.09 66 8.4 
8 312 2.86 0.68 76 7.3 
* GFR calculated from bolus inulin clearance method (Equations 10-11) 
 
4.2 Plasma Creatinine  
Maximum changes in plasma creatinine concentrations were found to occur between 
6 and 20 hours post induction of ARF, as indicated in Table 3. Estimated GFR values 
obtained from Equation (13) are shown in Table 3, where the fitting factor refers to 
the constant in Equation (13) when data is fitted in a rat-specific manner, as opposed 
to across the tested rat population. This deviation in fitting factor gives some 
indication of the expected error in the GFR estimation when compared to the inulin-
clearance estimated GFR.  
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Table 3. Creatinine GFR Estimation 
Rat 
GFR (mL/min)* 
% decrease 
Fitting factor 
(µmol/min/kg) 
Hours to max. 
conc. Normal ARF 
1 2.59 1.09 58 235 6 
2 2.56 0.33 87 217 20 
3 2.69 0.90 67 222 6 
4 2.49 1.21 51 243 20 
5 2.63 0.92 65 210 6 
6 2.43 1.01 58 209 6 
7 3.25 1.05 68 207 6 
8 2.78 0.78 72 212 6 
* GFR calculated using creatinine clearance (Equation 13) 
 
4.3 SIFT-MS Breath Analysis  
Selected Ion Mode (SIM) scans for ammonia were performed on rat breath samples, 
and converted to GFR estimates as summarized in Table 4. The decreases (%) in 
renal function results show excellent correlation with the inulin estimations of Table 
2, with a Pearson product-moment correlation coefficient of 0.89. 
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Table 4. Breath Ammonia Determination of GFR 
Rat 
GFR (mL/min)* 
% decrease 
Hours to max. 
conc. Normal ARF 
1 2.56 1.09 57 6 
2 2.75 0.42 85 20 
3 2.92 0.86 71 6 
4 2.35 1.17 50 6 
5 3.08 0.82 73 6 
6 2.31 1.21 48 6 
7 3.13 1.44 54 6 
8 2.96 0.85 71 6 
* GFR calculated from Breath ammonia concentration (Equation 18) 
 
Error in the GFR estimation is due to the oscillation in ammonia concentration as 
recorded by the SIFT-MS, and seen in Fig. 9. Fig. 9 shows the ammonia 
concentration as recorded by the SIFT-MS machine. The machine starts recording 
just before the sample is injected to obtain a background concentration, and then it 
takes approximately 20s to reach an equilibrium value. A probability density function 
can be formed around the concentration data, to obtain the inter quartile range of 
ammonia concentration. Because of the similar flowrates between breath and machine 
sampling, the error is effectively amplified in the current study when CTot and CB are 
combined to obtain CR.  However, with the introduction of a new Voice200® SIFT-
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MS machine, which samples at the lower rate of 2mL/min (as opposed to 2mL/sec), 
this error could be minimized in future studies. 
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Fig. 9. Oscillation in Ammonia SIM Scan 
 
4.4 Comparison in GFR Estimations  
Very good correlations were observed between the percentage decreases in renal 
function estimated by the 3 different methods. When the population metrics of 
Equation (13) and Equation (18) were combined for the plasma creatinine and breath 
ammonia data to obtain GFR estimates, Figs. 10-17 were obtained for the 8 rats.  
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Fig. 10. Rat 1 GFR Comparision 
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Fig. 11. Rat 2 GFR Comparision 
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Fig. 12. Rat 3 GFR Comparision 
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Fig. 13. Rat 4 GFR Comparision 
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Fig. 14. Rat 5 GFR Comparision 
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Fig. 15. Rat 6 GFR Comparision 
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Fig. 16. Rat 7 GFR Comparision 
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Fig. 17. Rat 8 GFR Comparision 
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Figs. 10-17 show the time-course for GFR estimation via the 3 methods for each 
subject rat. An initial decrease in GFR was caused by surgery alone, and the second, 
larger decrease in GFR was due to ARF. It is noted that the true GFR would be 
approximately zero immediately following the renal clamping. However, it would be 
impractical to perform an inulin clearance test at that time point when urine output is 
usually zero or minimal for some hours.  Using creatinine and breath measures, the GFR 
estimation would never reach that minimum value due to the time required for the 
creatinine/ammonia to build up in the blood/breath, and the reality that by the time 
they did, renal function would already be improving. Error bars indicate the 
variability of SIFT-MS. Better technology with the Voice200®, and filtering of 
multiple samples would reduce this error and further improve correlations.  
 
5. Conclusions 
ARF was induced in 8 rats, and the degree of renal failure was estimated using 3 
different methods: bolus radio-labelled inulin clearance test, plasma creatinine 
measurement, and SIFT-MS breath analyte monitoring. The relative decrease in 
function is the most useful metric, for which the Pearson product-moment correlation 
coefficient was 0.89 between breath and inulin techniques. However, a population 
model for absolute GFR estimation was also able to be generated from creatinine and 
breath data with very good correlations observed in Figs. 10-17.  
 
It was found in a pilot study (Fig. 5), that the concentration of expired ammonia 
increases as a function of background ammonia concentration with a slope greater 
than 1. This result indicates that ammonia can be removed from the body at a 
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concentration greater than that possible by simple diffusion from the blood, alone, 
suggesting the presence of ammonia transporters in lung epithelium for actively 
transporting ammonia. 
 
Determination of renal function via SIFT-MS is attractive since results are available 
non-invasively and in real time. Correlation between relative decreases in renal 
function presented here, indicate good promise for fast, non-invasive determination of 
renal function via breath testing. However, further development would be required to 
make this a viable and cost-effective clinical solution. 
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